Morgan Stanley Royalty Pharma PLC Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Royalty Pharma PLC stock. As of the latest transaction made, Morgan Stanley holds 44,217,885 shares of RPRX stock, worth $1.21 Billion. This represents 0.11% of its overall portfolio holdings.
Number of Shares
44,217,885
Previous 46,354,266
4.61%
Holding current value
$1.21 Billion
Previous $1.3 Billion
3.13%
% of portfolio
0.11%
Previous 0.12%
Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
395Shares Held
275MCall Options Held
276KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA37.7MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$581 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$457 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$315 Million1.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.8MShares$296 Million0.64% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...